arrow
返回
K

Kyle L. Kolaja

roche holding

37H指数
90论文数
5.3K被引数
收录论文 37
发表时间
SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site studySACF和GILA用于体外评估CRISPR/Cas9编辑的细胞治疗候选物的转化能力:一项多中心研究
err2026-07-29
err0
errOAAI
errLena Dorsheimer; Joana Rita Ferreira; Bojing Wang; Rebecca Bohnert; Rashade Haynes II; Sabine Kaiser; Andreas Neerincx; Corinna Smolarek; Louise Delsing; Benoit Fischer; Stefanie Könen; Andreas Schulz; Kyle L. Kolaja; Ridhirama Bhuwania; Connie L. Chen; Lucilia Pereira Mouriès; Mick Fellows; Silvana Libertini; Myriam Lemmens
err分享
err收藏
Immunogenicity Risk Assessment of Process-Related Impurities in An Engineered T Cell Receptor Cellular Product
err2024-08-01
err0
PREAI
errMora, Johanna; Forman, Daron; Hu, Jennifer; Ijantkar, Akshata; Gokemeijer, Jochem; Kolaja, Kyle L.; Picarillo, Caryn; Jawa, Vibha; Yue, Hai; Lamy, Juliette; Denies, Sofie; Schockaert, Jana; Ackaert, Chloe
err分享
err收藏
err分享
err收藏
Investigation Into the Role of ERK in Tyrosine Kinase Inhibitor-Induced Neuropathy
err2021-03-22
err6
PREAI
errBelair, David G.; Sudak, Katelyn; Connelly, Kimberly; Collins, Nathaniel D.; Kopytek, Stephan J.; Kolaja, Kyle L.
err分享
err收藏
Cardiovascular microphysiological systems (CVMPS) for safety studies - a pharma perspective
err2021-01-01
err15
PREAI
errPointon, Amy; Maher, Jonathan; Davis, Myrtle; Baker, Thomas; Cichocki, Joseph; Ramsden, Diane; Hale, Christopher; Kolaja, Kyle L.; Levesque, Paul; Sura, Radhakrishna; Stresser, David M.; Gintant, Gary
err分享
err收藏
Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective
err2020-11-01
err2
PREAI
errReynolds, Vincent L.; Butler, Paul; Abernathy, Matthew M.; Aschenbrenner, Laura; Best, Derek D.; Blank, Jim; Crosby, Meredith; Custer, Laura; Escobar, Patricia A.; Kolaja, Kyle; Moggs, Jonathan; Shuey, Dana; Snyder, Chelsea; Van Vleet, Terry; Zhou, Junguo; Hart, Timothy K.
err分享
err收藏
Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4
err2020-02-18
err25
errOAAI
errBelair, David G.; Lu, Gang; Waller, Laura E.; Gustin, Jason A.; Collins, Nathaniel D.; Kolaja, Kyle L.
err分享
err收藏
Developing in vitro assays to transform gastrointestinal safety assessment: potential for microphysiological systems
err2020-01-01
err57
errOAAI
errPeters, Matthew F.; Choy, Allison L.; Pin, Carmen; Leishman, Derek J.; Moisan, Annie; Ewart, Lorna; Guzzie-Peck, Peggy J.; Sura, Radhakrishna; Keller, Douglas A.; Scott, Clay W.; Kolaja, Kyle L.
err分享
err收藏
Cardiovascular Toxicity Induced by Kinase Inhibitors: Mechanisms and Preclinical Approaches
err2019-12-16
err53
errOAAI
errLamore, Sarah D.; Kohnken, Rebecca A.; Peters, Matthew F.; Kolaja, Kyle L.
err分享
err收藏
A comparison of 24 chemicals in the six-well bacterial reverse mutation assay to the standard 100-mm Petri plate bacterial reverse mutation assay in two laboratories
err2018-12-01
err5
PREAI
errNicolette, J.; Dakoulas, E.; Pant, K.; Crosby, M.; Kondratiuk, A.; Murray, J.; Sonders, P.; Kulkarni, R.; Jayakumar, G.; Mathur, M.; Patel, A.; Vicente, R.; Datta, K.; Kolaja, K.
err分享
err收藏
Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells
err2014-11-01
err213
errOAAI
errDrawnel, Faye M.; Boccardo, Stefano; Prummer, Michael; Delobel, Frederic; Graff, Alexandra; Weber, Michael; Gerard, Regine; Badi, Laura; Kam-Thong, Tony; Bu, Lei; Jiang, Xin; Hoflack, Jean-Christophe; Kiialainen, Anna; Jeworutzki, Elena; Aoyama, Natsuyo; Carlson, Coby; Burcin, Mark; Gromo, Gianni; Boehringer, Markus; Stahlberg, Henning; Hall, Benjamin J.; Magnone, Maria Chiara; Kolaja, Kyle; Chien, Kenneth R.; Bailly, Jacques; Iacone, Roberto
err分享
err收藏
Human Stem Cell-Derived Cardiomyocytes in Cellular Impedance Assays: Bringing Cardiotoxicity Screening to the Front Line
err2014-08-19
err81
PREAI
errPeters, Matthew F.; Lamore, Sarah D.; Guo, Liang; Scott, Clay W.; Kolaja, Kyle L.
err分享
err收藏
A High-Throughput Screen for Teratogens Using Human Pluripotent Stem Cells
err2013-10-23
err65
errOAAI
errKameoka, Sei; Babiarz, Joshua; Kolaja, Kyle; Chiao, Eric
err分享
err收藏
Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model
err2013-09-18
err111
errOAAI
errGuo, Liang; Coyle, Luke; Abrams, Rory M. C.; Kemper, Raymond; Chiao, Eric T.; Kolaja, Kyle L.
err分享
err收藏
err分享
err收藏
HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium
err2011-11-01
err33
PREAI
errGeenen, Suzanne; Guallar-Hoyas, Cristina; Michopoulos, Filippos; Kenna, J. Gerry; Kolaja, Kyle L.; Westerhoff, Hans V.; Thomas, Paul; Wilson, Ian D.
err分享
err收藏
Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes使用人诱导多能干细胞衍生的心肌细胞评估药物诱导的心律失常的风险
err2011-06-20
err242
errOAAI
errGuo, Liang; Abrams, Rory M. C.; Babiarz, Joshua E.; Cohen, Jennifer D.; Kameoka, Sei; Sanders, Martin J.; Chiao, Eric; Kolaja, Kyle L.
err分享
err收藏
HPLC-MS/MS methods for the quantitative analysis of ophthalmic acid in rodent plasma and hepatic cell line culture medium
err2011-04-01
err18
PREAI
errGeenen, Suzanne; Michopoulos, Filippos; Kenna, J. Gerry; Kolaja, Kyle L.; Westerhoff, Hans V.; Wilson, Ian
err分享
err收藏